Company Analysis

Oramed Pharmaceuticals Inc. (ORMP)

Nasdaq: ORMP · Pharmaceutical Preparations · New York, NY · filing with the SEC since 2002
Grade5.3
◀ Past 6.0● Present 6.0▶ Future 4.3

Filings

247 filings since 2017 beside 199 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by May 15, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Aug 3, 2026.

Filings a yearinsider forms included
3838604938464457
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 7 times in the last 36 months, the newest Dec 31, 2025.A late-filing notice, Form NT 10-Q, filed May 15, 2026.
Insider forms 199

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 12, 2026 10-Q Quarterly report Sep 30, 2026
Sep 17, 2026 8-K item 5.07 Shareholder vote · Current report Sep 15, 2026
Aug 14, 2026 SCHEDULE 13G/A Large holder update, amended
Aug 10, 2026 10-Q Quarterly report Jun 30, 2026
Aug 3, 2026 ARS Annual report to shareholders Dec 31, 2025
Aug 3, 2026 DEFA14A Extra proxy material
Aug 3, 2026 DEF 14A Proxy statement Sep 15, 2026
Jul 22, 2026 SCHEDULE 13D/A Activist holder update, amended
Jun 30, 2026 8-K items 5.03, 8.01, 9.01 Charter, bylaw or fiscal-year change; Other event · Current report Jun 25, 2026
Jun 29, 2026 SCHEDULE 13G/A Large holder update, amended
Jun 17, 2026 SCHEDULE 13D/A Activist holder update, amended
May 19, 2026 10-Q Quarterly report Mar 31, 2026
May 15, 2026 SCHEDULE 13G Large holder notice
May 15, 2026 NT 10-Q Late quarterly report notice Mar 31, 2026
May 14, 2026 SCHEDULE 13D Activist holder notice
Mar 31, 2026 8-K items 1.01, 2.01 Major agreement signed; Purchase or sale of a business completed · Current report Mar 25, 2026
Mar 26, 2026 10-K Annual report Dec 31, 2025
Feb 20, 2026 8-K items 1.01, 9.01 Major agreement signed · Current report Feb 19, 2026
Feb 19, 2026 SCHEDULE 13D/A Activist holder update, amended
Feb 13, 2026 SCHEDULE 13G/A Large holder update, amended
Feb 9, 2026 SCHEDULE 13G/A Large holder update, amended
Jan 29, 2026 SCHEDULE 13D Activist holder notice
Jan 14, 2026 8-K items 1.01, 8.01, 9.01 Major agreement signed; Other event · Current report Jan 12, 2026
Jan 7, 2026 8-K items 8.01, 9.01 Other event · Current report
Dec 31, 2025 8-K item 5.02 Officer or director change · Current report
Dec 31, 2025 8-K item 8.01 Other event · Current report Dec 30, 2025
Nov 17, 2025 8-K items 2.02, 9.01 Results released · Current report
Nov 17, 2025 8-A12B Class of securities registered for listing
Nov 17, 2025 8-K items 1.01, 3.03, 9.01 Major agreement signed; Change to shareholders' rights · Current report Nov 16, 2025
Nov 14, 2025 SCHEDULE 13G/A Large holder update, amended
Nov 13, 2025 10-Q Quarterly report Sep 30, 2025
Oct 24, 2025 8-K items 1.01, 1.02, 2.02, 8.01, 9.01 Major agreement signed; Major agreement ended; Results released; Other event · Current report Oct 20, 2025
Oct 6, 2025 8-K item 8.01 Other event · Current report Sep 30, 2025
Aug 28, 2025 SCHEDULE 13D/A Activist holder update, amended
Aug 21, 2025 S-8 Employee stock plan registration
Aug 21, 2025 8-K items 5.02, 5.07 Officer or director change; Shareholder vote · Current report Aug 19, 2025
Aug 14, 2025 SCHEDULE 13G/A Large holder update, amended
Aug 14, 2025 10-Q Quarterly report Jun 30, 2025
Jul 23, 2025 8-K items 1.01, 8.01, 9.01 Major agreement signed; Other event · Current report Jul 22, 2025
Jul 16, 2025 ARS Annual report to shareholders Dec 31, 2024
40 of 247 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton ORMP · research, not advice